Miromatrix Medical logo
Miromatrix Medical
MIRO | NASDAQ
Chart Builder DCF Calculator
$3.39
+$0.02 (+0.59%)
At close: Dec 12, 2023, 04:00 PM ET

Miromatrix Medical Company Profile

Company profile explained

Company Profile

Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.

Key Executives

Name Position
James Douglas Chief Financial Officer & Secretary

Latest SEC Filings

No SEC filings available
View All SEC Filings ➞
Miromatrix Medical
Miromatrix Medical logo
Country United States
IPO Date Jun 24, 2021
Industry Biotechnology
Sector Healthcare
Employees 76
CEO Jeffrey James Ross

Contact Details

6455 Flying Cloud Drive Eden Prairie, Minnesota 55344 United States

Stock Details

Ticker Symbol MIRO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001527096
CUSIP Number 60471P108
ISIN Number US60471P1084
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.